Lithuania to Ban Flavored E-Cigarettes Starting November 2024

Oct.08.2024
Lithuania to Ban Flavored E-Cigarettes Starting November 2024
Lithuania to ban flavored e-cigarettes from November 2024, aiming to protect public health, especially young people, from harmful effects.

According to a report from Lrt on October 3rd, starting in November 2024, Lithuania will no longer allow e-cigarettes that contain added or natural sweeteners and liquid sugars.


Rytis Jokubauskas, Vice President of the Consumer Alliance, pointed out that banning flavored e-cigarettes, related e-liquids, and supplements is an important measure to protect public health, especially the young population that needs protection. The marketing of e-cigarettes often targets young people, and consumers often lack comprehensive and objective information about the consequences of using e-cigarettes. The ban helps to create a safer environment and reduce the occurrence of public health problems.


In Lithuania's official government-run e-cigarette stores, despite the ban on flavored tobacco, only the names have been removed from product packaging. Consumers can still obtain detailed information about e-cigarette flavors when they inquire. According to the State Consumer Rights Protection Authority (VVTAT), this dishonest practice makes regulatory work more difficult, as samples need to be sent to laboratories for testing. However, the majority of test results have shown that the samples contain prohibited substances.


Since the ban on selling e-cigarettes and e-cigarette liquids with flavors and scents (excluding tobacco flavor) went into effect on July 1, 2022, VVTAT has reviewed 23 cases and decided to impose fines ranging from €750 to €2000 on violators. Most of the decisions have been appealed to the courts, but some companies have already paid the fines. Currently, only a few first-instance courts have ruled that VVTAT's decisions are reasonable, and these rulings are still being appealed to higher courts. A representative of VVTAT stated that this information has been transmitted to the National Drug, Tobacco, and Alcohol Control Department (NTAKD), which has the authority to suspend or revoke sales licenses for tobacco products.


The VVTAT revealed that regulating laws require a significant amount of manpower and financial resources, including inspections, sample collection and testing at physical stores, and legal procedures. These costs are covered by the state budget, which is funded by the contributions of every Lithuanian citizen. The leaders of the National Tobacco Manufacturers Association (NTGA) and the Innovation Tobacco Products Association have noticed a lack of market supervision and are calling for the promotion of trust among sellers.


According to VVTAT, with the amendments to the Tobacco, Tobacco Products and Related Products Management Act taking effect on November 1, 2023, it is expected that regulations will become clearer and simpler, thus improving the implementation of legal oversight.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
CTT Pharmaceutical Holdings said it has signed a letter of intent with a U.S. company to conduct clinical trials and testing for several potential nicotine products using its patented oral thin-film technology.
Jun.18
Opinion | As EU Reviews Tobacco Rules, Experts Warn Against Overlooking Smokers’ Alternatives
Opinion | As EU Reviews Tobacco Rules, Experts Warn Against Overlooking Smokers’ Alternatives
As the European Commission reviews its tobacco and advertising rules, two experts who provided written comments to 2Firsts argue that future EU policy should not overlook adult smokers’ alternatives. Dr Garrett McGovern and Dr Carmen Escrig say regulators should weigh relative risk, adult switching, flavours, consumer behaviour and scientific uncertainty alongside youth protection.
Industry Insight
Jun.01
Global Tobacco Control Faces Regional Adaptation Test as Nicotine Markets Evolve, Asian Specialist Says
Global Tobacco Control Faces Regional Adaptation Test as Nicotine Markets Evolve, Asian Specialist Says
As e-cigarettes, heated tobacco products and nicotine pouches expand across global markets, a central question is gaining urgency: can tobacco control rely on a universal policy model? In an interview with 2Firsts, Asian public health and addiction medicine specialist Dr. Rashidi Mohamed bin Pakri Mohamed says Western experience remains relevant, but policies must be adapted to local culture, healthcare systems, enforcement capacity, illicit markets and clinical evidence.
Jul.08
Hawaii Restricts Vape Sales to FDA-Authorized Products, Disposable E-Cigarettes to Be Banned
Hawaii Restricts Vape Sales to FDA-Authorized Products, Disposable E-Cigarettes to Be Banned
Hawaii has enacted two new e-cigarette laws that significantly tighten market access requirements, requiring products to meet FDA authorization standards and banning disposable e-cigarette sales starting in 2027.
Jul.08
Special Report|South Korean Lawmaker Queries China Tobacco Regulator Over Synthetic Nicotine as Export-Rule Gaps Emerge
Special Report|South Korean Lawmaker Queries China Tobacco Regulator Over Synthetic Nicotine as Export-Rule Gaps Emerge
A South Korean lawmaker has asked China’s tobacco regulator to clarify rules for e-cigarettes containing synthetic nicotine amid questions over product declarations and possible tax losses. The dispute exposes gaps between Chinese export requirements and destination-market rules, while underscoring the global impact of China’s licensing and traceability policies.
Jul.10
PMI Q2 Revenue Rises 10.4% as IQOS and VEEV Expand, U.S. ZYN Growth Slows
PMI Q2 Revenue Rises 10.4% as IQOS and VEEV Expand, U.S. ZYN Growth Slows
Philip Morris International’s second-quarter net revenues rose 10.4% to a record $11.19 billion, as heated tobacco and e-vapor expanded across international markets. IQOS remained the main smoke-free growth engine, while VEEV shipments jumped 55.1%. In the United States, however, ZYN shipments increased just 1.8% and consumer offtake was broadly flat to slightly higher. Cigarette volumes also rose, showing that PMI’s transformation is advancing, but growth is becoming increasingly uneven across categories and markets.
PMI
Jul.22